# Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients

> **NCT00713921** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Saint Thomas Health**

## Conditions studied

- Urinary Incontinence
- Bladder Dysfunction

## Interventions

- **DRUG:** Fesoterodine Oral Product

## Key facts

- **NCT ID:** NCT00713921
- **Lead sponsor:** Saint Thomas Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-09-15
- **Primary completion:** 2014-01-17
- **Final completion:** 2014-01-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment and loss of funding
- **Last updated:** 2018-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00713921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00713921, "Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00713921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*